TTR and cardiac amyloidosis: Among potential therapeutic agents to treat transthyretin cardiac amyloidosis, Epigallocatechin-gallate (EGCG), a major polyphenol of green tea, could be of therapeutic interest, as EGCG is able to inhibit transthyretin amyloid fibril formation and disaggregate amyloid deposits [3].